News Daily News Weight Regained Within 18 Months of Stopping GLP-1 Drugs Michael O'Riordan January 08, 2026
News Daily News Thrombolysis May Be OK for DOAC-Treated Patients With Ischemic Stroke Todd Neale January 07, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Daily News Remission From Prediabetes Halves CV Risk: Registry Data Yael L. Maxwell December 19, 2025
News Daily News Chronic Pain Linked to Increased Risk for Incident Hypertension L.A. McKeown November 20, 2025
News Daily News Fish Oil Halves CV Risk in Patients on Dialysis: PISCES Yael L. Maxwell November 10, 2025
News Daily News PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI L.A. McKeown November 04, 2025
News Daily News Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Caitlin E. Cox October 22, 2025
News Daily News HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease Todd Neale October 02, 2025
News Daily News ESTREL: Levodopa Doesn’t Boost Rehab Benefits After Acute Stroke Todd Neale September 25, 2025
News Daily News European Experts Provide Advice on Managing CV Effects of COVID-19 Todd Neale September 19, 2025
News Daily News Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis Todd Neale August 13, 2025
News Daily News HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke Todd Neale August 11, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Daily News Baxdrostat Shows Promise in Uncontrolled or Resistant Hypertension L.A. McKeown July 14, 2025
News Daily News No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits Michael O'Riordan July 14, 2025
News Daily News Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis Michael O'Riordan July 03, 2025
News Daily News Weight-Loss Drug MariTide Gains Momentum in Phase II Trial Caitlin E. Cox June 25, 2025